查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1578281

全球抗真菌药物市场研究报告 - 2024 年至 2032 年行业分析、规模、份额、成长、趋势和预测

Global Antifungal Drugs Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
出版日期: | 出版商: Value Market Research | 英文 128 Pages | 商品交期: 最快1-2个工作天内

价格

全球抗真菌药物市场需求预计将从 2023 年的 215.2 亿美元达到近 318.5 亿美元的市场规模，2024-2032 年研究期间复合年增长率为 4.45%。

抗真菌药物是指主要用于治疗念珠菌病、癣、香港脚等多种感染的药物杀菌剂。这些药物可以透过医生处方轻鬆购买，而有些药物可以在柜檯购买。真菌感染是由于生物体通过分解活组织（也称为皮癣菌）而产生的。它们可以利用角蛋白并引起头髮、皮肤和指甲感染。这些药物的唯一目的是透过使细胞内容物破裂来抑制真菌细胞的生长。不卫生的环境可能会导致严重的皮肤感染。

市场动态

该市场的成长可归因于透过线上广告以及各种产品对产品可用性的认识不断提高。除此之外，免疫性疾病发生率的增加和环境条件的变化，以及许多传染病在个体之间传播的增加也推动了需求。曲霉菌病和念珠菌病等真菌感染数量的增加也导致预测期内的需求激增。然而，替代品的可用性阻碍了市场的成长。同时，采用先进技术製造多种药物并为全球多种传染病提供有效的治疗程序，将为未来几年的市场成长开闢新的途径。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具也对全球抗真菌药物市场的各个细分市场进行了包容性评估。抗真菌药物产业的成长和趋势为本研究提供了整体方法。

市场区隔

抗真菌药物市场报告的这一部分提供了国家和区域级别细分市场的详细资料，从而帮助策略师确定相应产品或服务的目标人群以及即将到来的机会。

按药物类别

  • 唑类
  • 棘白菌素
  • 多烯
  • 烯丙胺
  • 其他的

按指示

  • 皮癣菌病
  • 曲菌病
  • 念珠菌病
  • 其他的

依剂型分类

  • 口服药物
  • 药膏
  • 粉末
  • 其他的

按配销通路

  • 医院药房
  • 零售药房
  • 其他的

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲抗真菌药物市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。抗真菌药物市场的主要参与者包括诺华公司、辉瑞公司、拜耳公司、赛诺菲公司、默克公司、葛兰素史克公司、雅培公司、格伦马克公司、恩佐製药公司、安斯泰来製药公司。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章：前言

  • 报告说明
    • 客观的
    • 目标受众
    • 独特的销售主张 (USP) 和产品
  • 研究范围
  • 研究方法
    • 市场研究过程
    • 市场研究方法论

第 2 章：执行摘要

  • 市集亮点
  • 全球市场概况

第 3 章：抗真菌药物 - 产业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场限制
  • 机会
  • 产业动态
  • 波特五力分析
  • 市场吸引力分析
    • 按药品类别分類的市场吸引力分析
    • 按指标进行的市场吸引力分析
    • 按剂型分類的市场吸引力分析
    • 按配销通路分類的市场吸引力分析
    • 市场吸引力分析：按地区

第 4 章：价值链分析

  • 价值链分析
  • 原料分析
    • 原料清单
    • 原料厂商清单
    • 主要原物料价格走势
  • 潜在买家名单
  • 行销管道
    • 直效行销
    • 间接行销
    • 行销通路发展趋势

第 5 章：全球抗真菌药物市场分析：按药物类别

  • 按药物类别概述
  • 历史和预测数据
  • 按药物类别分析
  • 唑类
  • 棘白菌素
  • 多烯
  • 烯丙胺
  • 其他的

第 6 章：全球抗霉菌药物市场分析：依适应症分类

  • 按指示概述
  • 历史和预测数据
  • 按指标分析
  • 皮癣菌病
  • 曲菌病
  • 念珠菌病
  • 其他的

第 7 章：全球抗霉菌药物市场分析：按剂型

  • 按剂型概述
  • 历史和预测数据
  • 按剂型分析
  • 口服药物
  • 药膏
  • 粉末
  • 其他的

第 8 章：全球抗真菌药物市场分析：按分销管道

  • 配销通路概述
  • 历史和预测数据
  • 按配销通路分析
  • 医院药房
  • 零售药房
  • 其他的

第 9 章：全球抗霉菌药物市场分析：依地理位置

  • 区域展望
  • 介绍
  • 北美销售分析
    • 概览、历史与预测资料销售分析
    • 北美按细分市场销售分析
    • 北美按国家销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概览、历史与预测资料销售分析
    • 欧洲按细分市场销售分析
    • 欧洲按国家销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 义大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概览、历史与预测资料销售分析
    • 亚太地区按细分市场销售分析
    • 亚太地区按国家销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳洲销售分析
    • 东南亚销售分析
    • 亚太地区其他地区销售分析
  • 拉丁美洲销售分析
    • 概览、历史与预测资料销售分析
    • 拉丁美洲按细分市场销售分析
    • 拉丁美洲按国家销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉丁美洲其他地区销售分析
  • 中东和非洲销售分析
    • 概览、历史与预测资料销售分析
    • 中东和非洲按细分市场销售分析
    • 中东和非洲按国家销售分析
    • 沙乌地阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 中东其他地区和非洲销售分析

第 10 章：抗真菌药物公司的竞争格局

  • 抗真菌药物市场竞争
  • 伙伴关係/协作/协议
  • 併购
  • 新产品发布
  • 其他发展

第 11 章：公司简介

  • 顶级公司市占率分析
  • 市场集中度
  • Novartis AG
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Pfizer Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Bayer AG
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Sanofi
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Merck & Co. Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • GlaxoSmithKline Plc
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Abbott
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Glenmark
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Enzon Pharmaceuticals Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Astellas Pharma Inc
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态

註 - 在公司概况中，财务详细资讯和最新发展视情况而定，或对私人公司而言可能不包括在内

Product Code: VMR11214197

The global demand for Antifungal Drugs Market is presumed to reach the market size of nearly USD 31.85 Billion by 2032 from USD 21.52 Billion in 2023 with a CAGR of 4.45% under the study period 2024-2032.

Antifungal drugs refer to a pharmaceutical fungicide primarily used to treat many infections like candidiasis, ringworms, athletes' feet, and others. These drugs can easily be purchased through a doctor's prescription, whereas some are available over the counter. Fungal infections arise due to organism feed by breaking down the living tissues, also known as dermatophytes. They can utilize keratin protein and cause infection over hair, skin, and nails. The only purpose of these drugs is to inhibit the fungal cell from growing by making the cell's content break out. An unhygienic environment may drive to a severe condition in causing an infection on the skin.

MARKET DYNAMICS

The growth of this market can be attributed to rising awareness about the products' availability through online advertisement along with a wide range of products. In addition to this, increasing occurrences of immunological diseases and changing environmental conditions, and the rise in the spread of many infectious diseases from individual to individual are also boosting the demand. A rising number of fungal infections like aspergillosis and candidiasis are also upsurging the demand during the forecast period. However, the availability of substitute is hindering the market growth. At the same time, the adoption of advanced technologies in manufacturing many drugs and providing effective treatment procedures for diverse infectious diseases globally is ready to create a new avenue for market growth in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Antifungal Drugs. The growth and trends of Antifungal Drugs industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Antifungal Drugs market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Drug Class

  • Azoles
  • Echinocandins
  • Polyenes
  • Allylamines
  • Others

By Indication

  • Dermatophytosis
  • Aspergillosis
  • Candidiasis
  • Others

By Dosage Form

  • Oral Drugs
  • Ointments
  • Powders
  • Others

By Distribution Channel

  • Hospital Pharmacies
  • Retails Pharmacies
  • Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Antifungal Drugs market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Antifungal Drugs market include Novartis AG, Pfizer Inc., Bayer AG, Sanofi, Merck & Co. Inc., GlaxoSmithKline Plc, Abbott, Glenmark, Enzon Pharmaceuticals Inc., Astellas Pharma Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. ANTIFUNGAL DRUGS - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Drug Class
    • 3.7.2 Market Attractiveness Analysis By Indication
    • 3.7.3 Market Attractiveness Analysis By Dosage Form
    • 3.7.4 Market Attractiveness Analysis By Distribution Channel
    • 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL ANTIFUNGAL DRUGS MARKET ANALYSIS BY DRUG CLASS

  • 5.1. Overview By Drug Class
  • 5.2. Historical and Forecast Data
  • 5.3. Analysis By Drug Class
  • 5.4. Azoles Historic and Forecast Sales By Regions
  • 5.5. Echinocandins Historic and Forecast Sales By Regions
  • 5.6. Polyenes Historic and Forecast Sales By Regions
  • 5.7. Allylamines Historic and Forecast Sales By Regions
  • 5.8. Others Historic and Forecast Sales By Regions

6. GLOBAL ANTIFUNGAL DRUGS MARKET ANALYSIS BY INDICATION

  • 6.1. Overview By Indication
  • 6.2. Historical and Forecast Data
  • 6.3. Analysis By Indication
  • 6.4. Dermatophytosis Historic and Forecast Sales By Regions
  • 6.5. Aspergillosis Historic and Forecast Sales By Regions
  • 6.6. Candidiasis Historic and Forecast Sales By Regions
  • 6.7. Others Historic and Forecast Sales By Regions

7. GLOBAL ANTIFUNGAL DRUGS MARKET ANALYSIS BY DOSAGE FORM

  • 7.1. Overview By Dosage Form
  • 7.2. Historical and Forecast Data
  • 7.3. Analysis By Dosage Form
  • 7.4. Oral Drugs Historic and Forecast Sales By Regions
  • 7.5. Ointments Historic and Forecast Sales By Regions
  • 7.6. Powders Historic and Forecast Sales By Regions
  • 7.7. Others Historic and Forecast Sales By Regions

8. GLOBAL ANTIFUNGAL DRUGS MARKET ANALYSIS BY DISTRIBUTION CHANNEL

  • 8.1. Overview By Distribution Channel
  • 8.2. Historical and Forecast Data
  • 8.3. Analysis By Distribution Channel
  • 8.4. Hospital Pharmacies Historic and Forecast Sales By Regions
  • 8.5. Retails Pharmacies Historic and Forecast Sales By Regions
  • 8.6. Others Historic and Forecast Sales By Regions

9. GLOBAL ANTIFUNGAL DRUGS MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook
  • 9.2. Introduction
  • 9.3. North America Sales Analysis
    • 9.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.3.2 North America By Segment Sales Analysis
    • 9.3.3 North America By Country Sales Analysis
    • 9.3.4 United States Sales Analysis
    • 9.3.5 Canada Sales Analysis
    • 9.3.6 Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.4.2 Europe By Segment Sales Analysis
    • 9.4.3 Europe By Country Sales Analysis
    • 9.4.4 United Kingdom Sales Analysis
    • 9.4.5 France Sales Analysis
    • 9.4.6 Germany Sales Analysis
    • 9.4.7 Italy Sales Analysis
    • 9.4.8 Russia Sales Analysis
    • 9.4.9 Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.5.2 Asia Pacific By Segment Sales Analysis
    • 9.5.3 Asia Pacific By Country Sales Analysis
    • 9.5.4 China Sales Analysis
    • 9.5.5 India Sales Analysis
    • 9.5.6 Japan Sales Analysis
    • 9.5.7 South Korea Sales Analysis
    • 9.5.8 Australia Sales Analysis
    • 9.5.9 South East Asia Sales Analysis
    • 9.5.10 Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.6.2 Latin America By Segment Sales Analysis
    • 9.6.3 Latin America By Country Sales Analysis
    • 9.6.4 Brazil Sales Analysis
    • 9.6.5 Argentina Sales Analysis
    • 9.6.6 Peru Sales Analysis
    • 9.6.7 Chile Sales Analysis
    • 9.6.8 Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.7.2 Middle East & Africa By Segment Sales Analysis
    • 9.7.3 Middle East & Africa By Country Sales Analysis
    • 9.7.4 Saudi Arabia Sales Analysis
    • 9.7.5 UAE Sales Analysis
    • 9.7.6 Israel Sales Analysis
    • 9.7.7 South Africa Sales Analysis
    • 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE ANTIFUNGAL DRUGS COMPANIES

  • 10.1. Antifungal Drugs Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11. COMPANY PROFILES OF ANTIFUNGAL DRUGS INDUSTRY

  • 11.1. Top Companies Market Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. Novartis AG
    • 11.3.1 Company Overview
    • 11.3.2 Company Revenue
    • 11.3.3 Products
    • 11.3.4 Recent Developments
  • 11.4. Pfizer Inc.
    • 11.4.1 Company Overview
    • 11.4.2 Company Revenue
    • 11.4.3 Products
    • 11.4.4 Recent Developments
  • 11.5. Bayer AG
    • 11.5.1 Company Overview
    • 11.5.2 Company Revenue
    • 11.5.3 Products
    • 11.5.4 Recent Developments
  • 11.6. Sanofi
    • 11.6.1 Company Overview
    • 11.6.2 Company Revenue
    • 11.6.3 Products
    • 11.6.4 Recent Developments
  • 11.7. Merck & Co. Inc.
    • 11.7.1 Company Overview
    • 11.7.2 Company Revenue
    • 11.7.3 Products
    • 11.7.4 Recent Developments
  • 11.8. GlaxoSmithKline Plc
    • 11.8.1 Company Overview
    • 11.8.2 Company Revenue
    • 11.8.3 Products
    • 11.8.4 Recent Developments
  • 11.9. Abbott
    • 11.9.1 Company Overview
    • 11.9.2 Company Revenue
    • 11.9.3 Products
    • 11.9.4 Recent Developments
  • 11.10. Glenmark
    • 11.10.1 Company Overview
    • 11.10.2 Company Revenue
    • 11.10.3 Products
    • 11.10.4 Recent Developments
  • 11.11. Enzon Pharmaceuticals Inc.
    • 11.11.1 Company Overview
    • 11.11.2 Company Revenue
    • 11.11.3 Products
    • 11.11.4 Recent Developments
  • 11.12. Astellas Pharma Inc
    • 11.12.1 Company Overview
    • 11.12.2 Company Revenue
    • 11.12.3 Products
    • 11.12.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Drug Class (USD MN)
  • Azoles Market Sales By Geography (USD MN)
  • Echinocandins Market Sales By Geography (USD MN)
  • Polyenes Market Sales By Geography (USD MN)
  • Allylamines Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By Indication (USD MN)
  • Dermatophytosis Market Sales By Geography (USD MN)
  • Aspergillosis Market Sales By Geography (USD MN)
  • Candidiasis Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By Dosage Form (USD MN)
  • Oral Drugs Market Sales By Geography (USD MN)
  • Ointments Market Sales By Geography (USD MN)
  • Powders Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By Distribution Channel (USD MN)
  • Hospital Pharmacies Market Sales By Geography (USD MN)
  • Retails Pharmacies Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Antifungal Drugs Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Antifungal Drugs Report
  • Market Research Process
  • Market Research Methodology
  • Global Antifungal Drugs Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Drug Class
  • Market Attractiveness Analysis By Indication
  • Market Attractiveness Analysis By Dosage Form
  • Market Attractiveness Analysis By Distribution Channel
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Drug Class (USD MN)
  • Azoles Market Sales By Geography (USD MN)
  • Echinocandins Market Sales By Geography (USD MN)
  • Polyenes Market Sales By Geography (USD MN)
  • Allylamines Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By Indication (USD MN)
  • Dermatophytosis Market Sales By Geography (USD MN)
  • Aspergillosis Market Sales By Geography (USD MN)
  • Candidiasis Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By Dosage Form (USD MN)
  • Oral Drugs Market Sales By Geography (USD MN)
  • Ointments Market Sales By Geography (USD MN)
  • Powders Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By Distribution Channel (USD MN)
  • Hospital Pharmacies Market Sales By Geography (USD MN)
  • Retails Pharmacies Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.